![Avri Havron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Avri Havron
Direktor/Vorstandsmitglied bei
COLLPLANT BIOTECHNOLOGIES LTD.
Vermögen: 152 927 $ am 31.05.2026
Profil
Dr. Abraham Havron is an Independent Director at CollPlant Biotechnologies Ltd. and an Independent Director at Enlivex Therapeutics Ltd. He is on the Board of Directors at CollPlant Ltd., CollPlant Biotechnologies Ltd. and Enlivex Therapeutics Ltd. Dr. Havron was previously employed as an Independent External Director by MediWound Ltd., an Independent Director by Kamada Ltd., a Chief Executive Officer & Director by OPKO Biologics Ltd., a Chief Executive Officer & Director by Prolor Biotech Ltd., a Chief Technology Officer & Vice President by Clal Biotechnology Industries Ltd., a Vice President-Manufacturing & Process Development by Biotechnology General (Israel) Ltd., and a Director-Research & Development by Interpharm Laboratories Ltd. He also served on the board at Pam-Bio Ltd. and Enlivex Therapeutics Ltd. /Old/.
He received his undergraduate degree from The Hebrew University of Jerusalem and a doctorate degree from Weizmann Institute of Science.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ENLIVEX LTD. 0.08% | 18.03.2026 | 183’836 ( 0.08% ) | 148 907 $ | 31.05.2026 |
| 18.03.2026 | 10’000 ( 0.07% ) | 4 020 $ | 31.05.2026 |
Aktive Positionen von Avri Havron
| Unternehmen | Position | Beginn |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Direktor/Vorstandsmitglied | 01.05.2016 |
| ENLIVEX LTD. | Direktor/Vorstandsmitglied | 01.01.2014 |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology Specializes in the development and commercialization of medical products | Direktor/Vorstandsmitglied | 01.05.2016 |
Ehemalige bekannte Positionen von Avri Havron
| Unternehmen | Position | Ende |
|---|---|---|
Pam-Bio Ltd.
 Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops drug therapy for acute bleeding conditions | Direktor/Vorstandsmitglied | 01.01.2019 |
| KAMADA LTD. | Direktor/Vorstandsmitglied | 20.12.2018 |
| MEDIWOUND LTD. | Direktor/Vorstandsmitglied | 22.06.2017 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Vorstandsvorsitzender | 01.01.2013 |
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Vorstandsvorsitzender | 01.01.2013 |
Ausbildung von Avri Havron
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
Clal Biotechnology Industries Ltd.
 Clal Biotechnology Industries Ltd. Financial ConglomeratesFinance Provides investment and support services for life science research companies | Finance |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
MediWound Ltd.
 MediWound Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes bio-therapeutic solutions for tissue repair and regeneration | Health Technology |
CollPlant Ltd.
CollPlant Ltd. BiotechnologyHealth Technology Specializes in the development and commercialization of medical products | Health Technology |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Health Technology |
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
CollPlant Biotechnologies Ltd.
 CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Pam-Bio Ltd.
Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops drug therapy for acute bleeding conditions | Health Technology |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Health Technology |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
